KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Exelixis (EXEL) over the last 14 years, with Oct 2025 value amounting to $30.9 million.

  • Exelixis' Share-based Compensation rose 34.15% to $30.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $119.2 million, marking a year-over-year increase of 29.89%. This contributed to the annual value of $93.8 million for FY2025, which is 11.76% down from last year.
  • Latest data reveals that Exelixis reported Share-based Compensation of $30.9 million as of Q4 2025, which was down 14.38% from $36.1 million recorded in Q3 2025.
  • Exelixis' Share-based Compensation's 5-year high stood at $64.3 million during Q1 2021, with a 5-year trough of $16.7 million in Q1 2023.
  • For the 3-year period, Exelixis' Share-based Compensation averaged around $26.6 million, with its median value being $25.4 million (2024).
  • Data for Exelixis' Share-based Compensation shows a peak YoY increase of 147.84% (in 2021) and a maximum YoY decrease of 63.98% (in 2021) over the last 5 years.
  • Over the past 5 years, Exelixis' Share-based Compensation (Quarterly) stood at $23.2 million in 2021, then increased by 11.61% to $25.9 million in 2022, then fell by 5.99% to $24.3 million in 2023, then slumped by 43.12% to $23.0 million in 2024, then spiked by 34.15% to $30.9 million in 2025.
  • Its last three reported values are $30.9 million in Q4 2025, $36.1 million for Q3 2025, and $25.9 million during Q2 2025.